iShares US Healthcare ETF

IYH

Market cap $3.2B

iShares U.S. Healthcare ETF provides broader exposure with 100 holdings compared to the 25 found in VanEck Biotech ETF VanEck Biotech ETF has delivered higher recent total returns but carries significantly greater historical price volatility iShares U.S. Healthcare ETF offers a higher dividend yield and lower five-year maximum drawdown for income-focused investors

Stretched tech valuations are reviving AI bubble fears. These ETFs can help navigate the uncertainty.

Big pharma's patent cliff risk is somewhat overstated, as layered IP and litigation often extend exclusivity beyond headline expiries. Incremental innovation—new formulations, improved delivery, and higher dosing—effectively extends product lifecycles and drives shareholder value.

Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the iShares U.S. Healthcare ETF (IYH), a passively managed exchange traded fund launched on June 12, 2000.

Simplify Health Care ETF carries a higher expense ratio but has significantly outperformed iShares U.S. Healthcare ETF over the past year iShares U.S. Healthcare ETF offers a higher dividend yield and lower price volatility as measured by its lower historical beta The Simplify fund follows an active mission-driven strategy targeting innovation while the iShares fund provides passive exposure to 102 healthcare stocks

The State Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio of 0.08% compared to 0.38% for the iShares U.S. Healthcare ETF The State Street Health Care Select Sector SPDR ETF provides a higher trailing-12-month dividend yield of 1.70% while the iShares U.S. Healthcare ETF offers 1.20% The iShares U.S. Healthcare ETF holds 102 stocks while the State Street Health Care Select Sector SPDR ETF concentrates on 60 large-cap names

Fidelity MSCI Health Care Index ETF (FHLC) offers a lower expense ratio and higher dividend than the iShares U.S. Healthcare ETF (IYH). IYH maintains a more concentrated portfolio, with 101 holdings compared to FHLC's 338 positions.

Geopolitical tensions and tech weakness are fueling volatility in U.S. markets. Explore ETFs for portfolio stability.

The recent rotation out of AI-linked stocks highlights the risks of a narrow market rally. As concentration risk rises, defensive ETFs could help investors build more resilient portfolios.

Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.